Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Medacta Group SA
  6. News
  7. Summary
    MOVE   CH0468525222

MEDACTA GROUP SA

(MOVE)
  Report
Delayed Swiss Exchange  -  11:30 2022-07-01 am EDT
91.40 CHF   +0.33%
06/23Medacta Announces First Lumbar Fusion Procedure with NextAR Augmented Reality Surgical Platform in Australia
EQ
05/24MEDACTA : Company Presentation
PU
05/19Medacta Group announces the results of today's Annual General Meeting
EQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Medacta FY21 Revenue Up 20% on Carryover, Customer Acquisition

01/20/2022 | 01:30am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
All news about MEDACTA GROUP SA
06/23Medacta Announces First Lumbar Fusion Procedure with NextAR Augmented Reality Surgical ..
EQ
05/24MEDACTA : Company Presentation
PU
05/19Medacta Group announces the results of today's Annual General Meeting
EQ
05/19Medacta Group SA Approves Distribution
CI
05/19Orthopedic Products Group Medacta Inaugurates New Offices In Switzerland
MT
05/18Medacta opens new offices in Rancate, Switzerland
EQ
05/18Medacta Group SA Opens New Offices in Rancate, Switzerland
CI
04/25Medacta's NextAR Spine Program Used in Lumbar Fusion Procedure in US
MT
04/25MEDACTA : Announces First Lumbar Fusion Procedure with NextAR Spine Augmented Reality Surg..
PU
04/25Medacta Announces First Lumbar Fusion Procedure with NextAR Spine Augmented Reality Sur..
EQ
More news
Analyst Recommendations on MEDACTA GROUP SA
More recommendations
Financials
Sales 2022 418 M 435 M 435 M
Net income 2022 61,1 M 63,6 M 63,6 M
Net Debt 2022 107 M 111 M 111 M
P/E ratio 2022 29,0x
Yield 2022 0,73%
Capitalization 1 825 M 1 898 M 1 898 M
EV / Sales 2022 4,62x
EV / Sales 2023 4,03x
Nbr of Employees 1 341
Free-Float 30,4%
Chart MEDACTA GROUP SA
Duration : Period :
Medacta Group SA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDACTA GROUP SA
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Last Close Price 91,28 €
Average target price 124,39 €
Spread / Average Target 36,3%
EPS Revisions
Managers and Directors
Francesco Siccardi Chief Executive Officer
Corrado Farsetta Chief Financial Officer
Alberto Siccardi Non-Executive Chairman
Victor Waldemar Balli Lead Independent Non-Executive Director
Philippe A. Weber Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
MEDACTA GROUP SA-35.63%1 898
ABBOTT LABORATORIES-21.69%192 989
MEDTRONIC PLC-11.67%121 417
BECTON, DICKINSON AND COMPANY2.45%71 779
BAXTER INTERNATIONAL INC.-23.71%32 976
HOYA CORPORATION-32.14%31 045